Followers | 1375 |
Posts | 28309 |
Boards Moderated | 59 |
Alias Born | 12/10/2012 |

Tuesday, November 30, 2021 8:32:09 AM
Sureeeeeeeeeeeeeeeeeeeeeeeee sure sureeeeeeeeeeeeeee
Now you can leave from here forever now that you're done ????
GO $HEPA
Recent HEPA News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 09:00:12 PM
- Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq • GlobeNewswire Inc. • 05/12/2025 08:30:00 PM
- Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC • GlobeNewswire Inc. • 05/07/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 12:59:37 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/23/2025 08:05:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2025 08:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2025 08:15:33 PM
- Hepion Pharmaceuticals Announces Reverse Stock Split • GlobeNewswire Inc. • 03/14/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2025 08:05:26 PM
- Hepion Pharmaceuticals Announces $9.0 Million Public Offering • GlobeNewswire Inc. • 01/22/2025 01:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/13/2025 12:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 01:26:23 PM
- Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd. • GlobeNewswire Inc. • 12/11/2024 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/05/2024 01:48:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/02/2024 01:53:12 PM
- Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B • GlobeNewswire Inc. • 12/02/2024 01:00:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/21/2024 10:01:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2024 10:00:40 PM
- Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger • GlobeNewswire Inc. • 11/11/2024 01:00:00 PM
- Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger • GlobeNewswire Inc. • 09/04/2024 01:25:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/07/2024 01:08:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 01:04:30 PM
- Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement • GlobeNewswire Inc. • 07/22/2024 12:00:00 PM
Authentic Events, LLC To Broadcast its First Pay Per View with Lingerie Fighting Championships on July 4th 2025 • AHRO • May 22, 2025 8:30 AM
Lingerie Fighting Championships Coming to the UK for July 4 & 6 Events • BOTY • May 19, 2025 10:00 AM
VAYK Projects to Report Over $400K Q1 Revenue • VAYK • May 15, 2025 9:00 AM
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone • VRHI • May 15, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer • BLO • May 14, 2025 8:51 AM
North Bay Resources Announces Resource Estimate of 474,000 ounces at Fran Gold Project, British Columbia • NBRI • May 13, 2025 9:58 AM